Trial intelligence / Profile preview

Preincisional Dextromethorphan for Postoperative Opioid Use in TKA

NCT02987920Phase 4Terminated

Sponsor
University of Southern California
Start
Jan 2017
Primary completion
Jan 2018
Modality
Small Molecules
01

Overview

Phase 4, randomised, double-blind trial in postoperative pain comparing Placebo with Dextromethorphan (2 arms). Primary endpoint: Total amount of postoperative opioid used in first 48 hours after knee replacement. Started Jan 2017; status: terminated.

02

Drugs

dextromethorphan
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT02987920.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02987920.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call